
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.4B | $1.8B | $2.9B | $4B | $4.3B | |
Revenue Growth (YoY) | 0.94% | 27.81% | 62.07% | 37.09% | 9.06% | |
Cost of Revenues | $1.3B | $1.6B | $2.6B | $3.6B | $4B | |
Gross Profit | $124.2M | $160.4M | $295M | $334.9M | $343M | |
Gross Profit Margin | 8.9% | 8.99% | 10.21% | 8.45% | 7.94% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $80.7M | $98.4M | $239.2M | $210.4M | $183.8M | |
Other Inc / (Exp) | -- | -- | -- | -$26.5M | -$12.5M | |
Operating Expenses | $80.7M | $98.4M | $239.2M | $210.4M | $183.8M | |
Operating Income | $43.5M | $62M | $55.8M | $124.4M | $159.2M | |
Net Interest Expenses | $4.8M | $8M | $61.9M | $122.4M | $107.9M | |
EBT. Incl. Unusual Items | $38.7M | $54M | -$6.1M | -$24.5M | $38.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.7M | $8.3M | $8.2M | -$1.9M | $4.2M | |
Net Income to Company | $37M | $45.7M | -$14.3M | -$22.6M | $34.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $37M | $45.7M | -$14.3M | -$22.6M | $34.7M | |
Basic EPS (Cont. Ops) | $3.19 | $3.91 | -$0.68 | -$0.73 | $1.10 | |
Diluted EPS (Cont. Ops) | $3.14 | $3.86 | -$0.68 | -$0.73 | $1.08 | |
Weighted Average Basic Share | $11.6M | $11.7M | $21M | $31.1M | $31.5M | |
Weighted Average Diluted Share | $11.8M | $11.8M | $21M | $31.1M | $32M | |
EBITDA | $51.6M | $78.6M | $118.4M | $212.2M | $262.9M | |
EBIT | $43.5M | $62M | $55.8M | $98.9M | $148M | |
Revenue (Reported) | $1.4B | $1.8B | $2.9B | $4B | $4.3B | |
Operating Income (Reported) | $43.5M | $62M | $55.8M | $124.4M | $159.2M | |
Operating Income (Adjusted) | $43.5M | $62M | $55.8M | $98.9M | $148M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $434M | $456.5M | $943.5M | $1B | $1B | |
Revenue Growth (YoY) | 23.39% | 5.18% | 106.69% | 7.11% | 0.53% | |
Cost of Revenues | $393.6M | $419.3M | $864.6M | $940.3M | $937.8M | |
Gross Profit | $40.4M | $37.2M | $78.8M | $70.3M | $78.1M | |
Gross Profit Margin | 9.3% | 8.15% | 8.36% | 6.95% | 7.69% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $23.8M | $32M | $48.3M | $39.9M | $43.8M | |
Other Inc / (Exp) | -- | -- | -$22.1M | -$1.6M | -$4.5M | |
Operating Expenses | $23.8M | $32M | $48.3M | $39.9M | $43.8M | |
Operating Income | $16.5M | $5.2M | $30.6M | $30.3M | $34.3M | |
Net Interest Expenses | $1.9M | $1.7M | $31.7M | $27.6M | $19.7M | |
EBT. Incl. Unusual Items | $14.6M | $3.6M | -$23.2M | $1.1M | $10.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.6M | $701K | -$5.7M | -$20K | $2M | |
Net Income to Company | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Basic EPS (Cont. Ops) | $1.03 | $0.24 | -$0.57 | $0.04 | $0.26 | |
Diluted EPS (Cont. Ops) | $1.02 | $0.24 | -$0.57 | $0.04 | $0.25 | |
Weighted Average Basic Share | $11.6M | $11.8M | $30.9M | $31.4M | $31.6M | |
Weighted Average Diluted Share | $11.8M | $11.9M | $30.9M | $31.8M | $32M | |
EBITDA | $20.6M | $9.2M | $36.8M | $57.8M | $58.1M | |
EBIT | $16.6M | $5.3M | $8.7M | $29M | $30M | |
Revenue (Reported) | $434M | $456.5M | $943.5M | $1B | $1B | |
Operating Income (Reported) | $16.5M | $5.2M | $30.6M | $30.3M | $34.3M | |
Operating Income (Adjusted) | $16.6M | $5.3M | $8.7M | $29M | $30M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.8B | $3.4B | $4B | $4.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.3B | $1.6B | $3B | $3.7B | $4B | |
Gross Profit | $132.5M | $157.3M | $336.6M | $326.3M | $350.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $84.9M | $106.5M | $255.5M | $202.1M | $187.6M | |
Other Inc / (Exp) | -- | -- | -$22.1M | -$6.1M | -$15.3M | |
Operating Expenses | $84.9M | $106.5M | $255.5M | $202.1M | $187.6M | |
Operating Income | $47.5M | $50.7M | $81.1M | $124.2M | $163.2M | |
Net Interest Expenses | $5M | $7.7M | $91.9M | $118.3M | $100M | |
EBT. Incl. Unusual Items | $42.5M | $43M | -$32.9M | -$177K | $47.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.2M | $6.5M | $1.8M | $3.8M | $6.1M | |
Net Income to Company | $40.3M | $36.5M | -$34.7M | -$3.9M | $41.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $40.3M | $36.5M | -$34.7M | -$3.9M | $41.6M | |
Basic EPS (Cont. Ops) | $3.47 | $3.11 | -$0.72 | -$0.13 | $1.32 | |
Diluted EPS (Cont. Ops) | $3.41 | $3.05 | -$0.73 | -$0.13 | $1.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $57.6M | $67.2M | $146M | $233.3M | $263.1M | |
EBIT | $47.5M | $50.7M | $59.2M | $119.1M | $149M | |
Revenue (Reported) | $1.5B | $1.8B | $3.4B | $4B | $4.3B | |
Operating Income (Reported) | $47.5M | $50.7M | $81.1M | $124.2M | $163.2M | |
Operating Income (Adjusted) | $47.5M | $50.7M | $59.2M | $119.1M | $149M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $434M | $456.5M | $943.5M | $1B | $1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $393.6M | $419.3M | $864.6M | $940.3M | $937.8M | |
Gross Profit | $40.4M | $37.2M | $78.8M | $70.3M | $78.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $23.8M | $32M | $48.3M | $39.9M | $43.8M | |
Other Inc / (Exp) | -- | -- | -$22.1M | -$1.6M | -$4.5M | |
Operating Expenses | $23.8M | $32M | $48.3M | $39.9M | $43.8M | |
Operating Income | $16.5M | $5.2M | $30.6M | $30.3M | $34.3M | |
Net Interest Expenses | $1.9M | $1.7M | $31.7M | $27.6M | $19.7M | |
EBT. Incl. Unusual Items | $14.6M | $3.6M | -$23.2M | $1.1M | $10.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.6M | $701K | -$5.7M | -$20K | $2M | |
Net Income to Company | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Basic EPS (Cont. Ops) | $1.03 | $0.24 | -$0.57 | $0.04 | $0.26 | |
Diluted EPS (Cont. Ops) | $1.02 | $0.24 | -$0.57 | $0.04 | $0.25 | |
Weighted Average Basic Share | $11.6M | $11.8M | $30.9M | $31.4M | $31.6M | |
Weighted Average Diluted Share | $11.8M | $11.9M | $30.9M | $31.8M | $32M | |
EBITDA | $20.6M | $9.2M | $36.8M | $57.8M | $58.1M | |
EBIT | $16.6M | $5.3M | $8.7M | $29M | $30M | |
Revenue (Reported) | $434M | $456.5M | $943.5M | $1B | $1B | |
Operating Income (Reported) | $16.5M | $5.2M | $30.6M | $30.3M | $34.3M | |
Operating Income (Adjusted) | $16.6M | $5.3M | $8.7M | $29M | $30M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $66.9M | $38.5M | $116.1M | $72.7M | $268.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $102M | $104.1M | $227.7M | $109.3M | $78M | |
Inventory | -- | -- | $45M | $47M | $50.9M | |
Prepaid Expenses | $16.1M | $21.2M | -- | $41.4M | $51.6M | |
Other Current Assets | $8.6M | $15.1M | $42.3M | $7.9M | $19.4M | |
Total Current Assets | $408.4M | $423.3M | $931.9M | $874.9M | $1.1B | |
Property Plant And Equipment | $41.3M | $67.4M | $131.5M | $126.6M | $99.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $339.7M | $321.7M | $1.7B | $1.7B | $1.7B | |
Other Intangibles | $48.1M | $66.6M | $498M | $407.5M | $323.1M | |
Other Long-Term Assets | $6.3M | $10.4M | $17.9M | $15.9M | $48.9M | |
Total Assets | $843.8M | $889.5M | $3.2B | $3.1B | $3.2B | |
Accounts Payable | $159.6M | $212.5M | $406.7M | $453.1M | $547.6M | |
Accrued Expenses | $67M | $70M | $82M | $184M | $250.8M | |
Current Portion Of Long-Term Debt | $8.6M | $10.4M | $11.9M | $15.4M | $20M | |
Current Portion Of Capital Lease Obligations | $6.2M | $12M | $17.6M | $13.6M | $11.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $288.4M | $358.2M | $783.1M | $840.2M | $996.2M | |
Long-Term Debt | $168.8M | $94.2M | $1.3B | $1.1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $538.9M | $539.4M | $2.2B | $2.1B | $2.2B | |
Common Stock | $116K | $117K | $305K | $312K | $316K | |
Other Common Equity Adj | -$27K | -$5.9M | -$5.5M | -$2.7M | -$9.4M | |
Common Equity | $304.9M | $350.1M | $997.1M | $990.8M | $1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $304.9M | $350.1M | $997.1M | $990.8M | $1B | |
Total Liabilities and Equity | $843.8M | $889.5M | $3.2B | $3.1B | $3.2B | |
Cash and Short Terms | $66.9M | $38.5M | $116.1M | $72.7M | $268.3M | |
Total Debt | $177.4M | $104.6M | $1.3B | $1.1B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $38.3M | $23M | $62.1M | $35.7M | $169.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $115.6M | $136.3M | $189.2M | $117.2M | $100.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $25.9M | $78.2M | -- | -- | |
Other Current Assets | $27.3M | $11.1M | $26M | $129.4M | $128.1M | |
Total Current Assets | $426.6M | $437.6M | $926.2M | $953.6M | $1B | |
Property Plant And Equipment | $42.2M | $66.1M | $130.9M | $131M | $97.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $315.4M | $321.7M | $1.7B | $1.6B | $1.7B | |
Other Intangibles | $71.3M | $64.3M | $475.3M | $389.4M | $300.5M | |
Other Long-Term Assets | $6.8M | $9.9M | $21.4M | $17.4M | $46.2M | |
Total Assets | $862.3M | $899.6M | $3.2B | $3.1B | $3.1B | |
Accounts Payable | $197.4M | $234.7M | $402.7M | $430.6M | $440.6M | |
Accrued Expenses | $41.2M | $55.4M | $198.1M | $267.4M | $282.1M | |
Current Portion Of Long-Term Debt | $9.2M | $10.4M | $15.5M | $15.4M | $19.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $304.2M | $359.6M | $760.2M | $852.7M | $867.1M | |
Long-Term Debt | $166.4M | $108.4M | $1.3B | $1.2B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $547.9M | $545.4M | $2.2B | $2.1B | $2.1B | |
Common Stock | $117K | $118K | $310K | $315K | $317K | |
Other Common Equity Adj | -$2.5M | -$6.1M | -$5.9M | -$179K | -$7.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $314.5M | $354.2M | $978.5M | $993.7M | $1B | |
Total Liabilities and Equity | $862.3M | $899.6M | $3.2B | $3.1B | $3.1B | |
Cash and Short Terms | $38.3M | $23M | $62.1M | $35.7M | $169.1M | |
Total Debt | $175.6M | $118.8M | $1.3B | $1.2B | $1.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $37M | $45.7M | -$14.3M | -$22.6M | $34.7M | |
Depreciation & Amoritzation | $8.1M | $16.6M | $62.6M | $113.3M | $114.9M | |
Stock-Based Compensation | $9.4M | $8.3M | $32.7M | $32.8M | $16M | |
Change in Accounts Receivable | $1M | -$36.4M | -$52.3M | $19.1M | $25.2M | |
Change in Inventories | -- | -$5.2M | -$3.6M | -$311K | -$4M | |
Cash From Operations | $64.1M | $61.3M | $93.5M | $188M | $254.2M | |
Capital Expenditures | $4.5M | $9.8M | $12.4M | $25M | $11.8M | |
Cash Acquisitions | -$133.6M | $262K | $188.4M | $1.3M | -$16.9M | |
Cash From Investing | -$138M | -$12.6M | $176M | -$22.6M | -$28.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $314M | $529M | $392M | $1.2B | $1.3B | |
Long-Term Debt Repaid | -$205.5M | -$602.6M | -$581.3M | -$1.4B | -$1.3B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.8M | -$2.4M | -$4.3M | -$28.5M | -$9.3M | |
Cash From Financing | $105.8M | -$75.6M | -$193.2M | -$211M | -$24.5M | |
Beginning Cash (CF) | $35.3M | $68.7M | $38.5M | $116.1M | $72.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $31.8M | -$26.9M | $76.2M | -$45.7M | $201.1M | |
Ending Cash (CF) | $68.7M | $38.5M | $116.1M | $72.7M | $268.3M | |
Levered Free Cash Flow | $59.6M | $51.6M | $81.1M | $162.9M | $242.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Depreciation & Amoritzation | $4M | $3.9M | $28M | $28.9M | $28M | |
Stock-Based Compensation | $2.6M | $2.6M | $12.9M | $5.1M | $2.5M | |
Change in Accounts Receivable | -$46.5M | -$29.9M | -$30.6M | -$55.4M | $6.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$21.7M | -$26.4M | -$38.5M | -$57.2M | -$95.5M | |
Capital Expenditures | $2.6M | $2.2M | $9.1M | $7.8M | $2.7M | |
Cash Acquisitions | -- | -- | -- | -$16.9M | -- | |
Cash From Investing | -$2.6M | -$2.2M | -$9.1M | -$24.7M | -$2.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $110M | $217M | $598.8M | $375.3M | $141M | |
Long-Term Debt Repaid | -$112M | -$202.6M | -$584.8M | -$323.1M | -$141M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.2M | -$2.1M | -$21.9M | -$5.7M | -$3.9M | |
Cash From Financing | -$4.1M | $12.3M | -$7.9M | $46.5M | -$3.8M | |
Beginning Cash (CF) | $68.7M | $38.5M | $116.1M | $72.7M | $268.3M | |
Foreign Exchange Rate Adjustment | -$191K | $729K | $1.6M | -$1.5M | $2.6M | |
Additions / Reductions | -$28.4M | -$16.2M | -$55.5M | -$35.5M | -$101.9M | |
Ending Cash (CF) | $40.1M | $23M | $62.1M | $35.7M | $169.1M | |
Levered Free Cash Flow | -$24.3M | -$28.6M | -$47.6M | -$65M | -$98.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $40.3M | $36.5M | -$34.7M | -$3.9M | $41.6M | |
Depreciation & Amoritzation | $10.1M | $16.4M | $86.8M | $114.1M | $114.1M | |
Stock-Based Compensation | $9.7M | $8.3M | $43.1M | $25.1M | $13.3M | |
Change in Accounts Receivable | -$49.5M | -$19.7M | -$53.1M | -$5.7M | $87M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $41.2M | $56.7M | $81.4M | $169.2M | $216M | |
Capital Expenditures | $6.2M | $9.4M | $19.3M | $23.7M | $6.7M | |
Cash Acquisitions | -$133.6M | $262K | $188.4M | -$15.6M | -- | |
Cash From Investing | -$139.7M | -$12.2M | $169.1M | -$38.3M | -$6.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $280M | $636M | $773.8M | $949.3M | $1B | |
Long-Term Debt Repaid | -$287M | -$693.2M | -$963.5M | -$1.1B | -$1.1B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.2M | -$2.3M | -$24.1M | -$12.2M | -$7.5M | |
Cash From Financing | -$10M | -$59.2M | -$213.5M | -$156.6M | -$74.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$108.5M | -$14.7M | $37M | -$25.7M | $134.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $35M | $47.3M | $62.1M | $145.5M | $209.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $12M | $2.9M | -$17.5M | $1.1M | $8.1M | |
Depreciation & Amoritzation | $4M | $3.9M | $28M | $28.9M | $28M | |
Stock-Based Compensation | $2.6M | $2.6M | $12.9M | $5.1M | $2.5M | |
Change in Accounts Receivable | -$46.5M | -$29.9M | -$30.6M | -$55.4M | $6.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$21.7M | -$26.4M | -$38.5M | -$57.2M | -$95.5M | |
Capital Expenditures | $2.6M | $2.2M | $9.1M | $7.8M | $2.7M | |
Cash Acquisitions | -- | -- | -- | -$16.9M | -- | |
Cash From Investing | -$2.6M | -$2.2M | -$9.1M | -$24.7M | -$2.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $110M | $217M | $598.8M | $375.3M | $141M | |
Long-Term Debt Repaid | -$112M | -$202.6M | -$584.8M | -$323.1M | -$141M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.2M | -$2.1M | -$21.9M | -$5.7M | -$3.9M | |
Cash From Financing | -$4.1M | $12.3M | -$7.9M | $46.5M | -$3.8M | |
Beginning Cash (CF) | $68.7M | $38.5M | $116.1M | $72.7M | $268.3M | |
Foreign Exchange Rate Adjustment | -$191K | $729K | $1.6M | -$1.5M | $2.6M | |
Additions / Reductions | -$28.4M | -$16.2M | -$55.5M | -$35.5M | -$101.9M | |
Ending Cash (CF) | $40.1M | $23M | $62.1M | $35.7M | $169.1M | |
Levered Free Cash Flow | -$24.3M | -$28.6M | -$47.6M | -$65M | -$98.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.